QQ客服 官方微博 反馈留言

	Orlistat Displays Antitumor Activity and Enhances the Efficacy of Paclitaxel in Human Hepatoma Hep3B Cells
	Bang-Jau You; Li-Yun Chen; Po-Hsiang Hsu; Pei-Hsuan Sung; Yu-Ching Hung; Hong-Zin Lee
刊名	Chemical Research in Toxicology
	2019
ISSN号	0893-228X;1520-5010
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4605632
专题	湖南大学
作者单位	Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 404, Taiwan School of Pharmacy, China Medical University, Taichung 404, Taiwan
推荐引用方式 GB/T 7714	Bang-Jau You,Li-Yun Chen,Po-Hsiang Hsu,et al. Orlistat Displays Antitumor Activity and Enhances the Efficacy of Paclitaxel in Human Hepatoma Hep3B Cells[J]. Chemical Research in Toxicology,2019.
APA	Bang-Jau You,Li-Yun Chen,Po-Hsiang Hsu,Pei-Hsuan Sung,Yu-Ching Hung,&Hong-Zin Lee.(2019).Orlistat Displays Antitumor Activity and Enhances the Efficacy of Paclitaxel in Human Hepatoma Hep3B Cells.Chemical Research in Toxicology.
MLA	Bang-Jau You,et al."Orlistat Displays Antitumor Activity and Enhances the Efficacy of Paclitaxel in Human Hepatoma Hep3B Cells".Chemical Research in Toxicology (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。